PPT1 anticorps (N-Term)
Aperçu rapide pour PPT1 anticorps (N-Term) (ABIN7188634)
Antigène
Voir toutes PPT1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Fonction
- PPT1 Antibody
-
Réactivité croisée
- Souris, Rat
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from the N-terminal region of Human CLN1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PPT1 (Palmitoyl-Protein Thioesterase 1 (PPT1))
-
Autre désignation
- PPT1
-
Sujet
- Ceroid palmitoyl palmitoyl protein thioesterase 1 antibody, CLN1 antibody, EC 3.1.2.22 antibody, INCL antibody, Palmitoyl protein hydrolase 1 antibody, Palmitoyl protein thioesterase 1 antibody, Palmitoyl-protein hydrolase 1 antibody, Palmitoyl-protein thioesterase 1 antibody, PPT antibody, PPT-1 antibody, PPT1 antibody, PPT1_HUMAN antibody
-
UniProt
- P50897
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-